Artículos de revistas sobre el tema "APOBEC family"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "APOBEC family".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Dang, Ying, Xiaojun Wang, Walter J. Esselman y Yong-Hui Zheng. "Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family". Journal of Virology 80, n.º 21 (18 de agosto de 2006): 10522–33. http://dx.doi.org/10.1128/jvi.01123-06.
Texto completoChu, Charles C., Stefano Vergani, Xiao-Jie Yan, Arvind Dhayalan, Piers E. M. Patten, Thomas MacCarthy, Chaohui Yuan et al. "APOBEC gene family expression and hallmarks in chronic lymphocytic leukemia". Journal of Immunology 198, n.º 1_Supplement (1 de mayo de 2017): 76.16. http://dx.doi.org/10.4049/jimmunol.198.supp.76.16.
Texto completoCaswell, Deborah y Charles Swanton. "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer". Cancer Research 83, n.º 4 (15 de febrero de 2023): 487–88. http://dx.doi.org/10.1158/0008-5472.can-22-3598.
Texto completoChu, Charles C., Xiao-Jie Yan, Arvind Dhayalan, Piers E. Patten, Thomas MacCarthy, Chaohui Yuan, Jacqueline C. Barrientos et al. "The Correlation of APOBEC Gene Family Member Expression with Worse CLL Patient Outcome Suggests a Role in CLL Mutational Evolution". Blood 126, n.º 23 (3 de diciembre de 2015): 363. http://dx.doi.org/10.1182/blood.v126.23.363.363.
Texto completoMikl, Marie C., Ian N. Watt, Mason Lu, Wolf Reik, Sarah L. Davies, Michael S. Neuberger y Cristina Rada. "Mice Deficient in APOBEC2 and APOBEC3". Molecular and Cellular Biology 25, n.º 16 (15 de agosto de 2005): 7270–77. http://dx.doi.org/10.1128/mcb.25.16.7270-7277.2005.
Texto completoHarris, Reuben S., Matthew C. Jarvis, Michael A. Carpenter, Margaret R. Brown, Prokopios P. Argyris, William Brown y Douglas Yee. "Abstract P5-12-01: Apobec mutation signature in breast cancer explained by combinatorial action of apobec3a and apobec3b". Cancer Research 82, n.º 4_Supplement (15 de febrero de 2022): P5–12–01—P5–12–01. http://dx.doi.org/10.1158/1538-7445.sabcs21-p5-12-01.
Texto completoTalluri, Srikanth, Mehmet Kemal Samur, Jialan Shi, Rao Prabhala, Hervé Avet-Loiseau, Masood A. Shammas y Nikhil Munshi. "Critical Role for Apobec and Its Interacting Partners in Mediating Mutations and Cell Growth in Multiple Myeloma (MM)". Blood 132, Supplement 1 (29 de noviembre de 2018): 4462. http://dx.doi.org/10.1182/blood-2018-99-118441.
Texto completoTalluri, Srikanth, Mehmet Kemal Samur, Leutz Buon, Stekla A. Megan, Purushothama Nanjappa, Rao Prabhala, Masood A. Shammas y Nikhil C. Munshi. "Dysregulated Aid/Apobec Family Proteins Promote Genomic Instability in Multiple Myeloma". Blood 128, n.º 22 (2 de diciembre de 2016): 803. http://dx.doi.org/10.1182/blood.v128.22.803.803.
Texto completoKöck, Josef y Hubert E. Blum. "Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H". Journal of General Virology 89, n.º 5 (1 de mayo de 2008): 1184–91. http://dx.doi.org/10.1099/vir.0.83507-0.
Texto completoGranadillo Rodríguez, Milaid, Ben Flath y Linda Chelico. "The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead". Open Biology 10, n.º 12 (diciembre de 2020): 200188. http://dx.doi.org/10.1098/rsob.200188.
Texto completoXu, Wendy Kaichun, Hyewon Byun y Jaquelin P. Dudley. "The Role of APOBECs in Viral Replication". Microorganisms 8, n.º 12 (30 de noviembre de 2020): 1899. http://dx.doi.org/10.3390/microorganisms8121899.
Texto completoLiu, Qin, Yue-wen Luo, Ruo-yan Cao, Xue Pan, Xi-juan Chen, Si-yuan Zhang, Wei-lin Zhang, Jia-ying Zhou, Bin Cheng y Xian-yue Ren. "Association between APOBEC3H-Mediated Demethylation and Immune Landscape in Head and Neck Squamous Carcinoma". BioMed Research International 2020 (25 de julio de 2020): 1–17. http://dx.doi.org/10.1155/2020/4612375.
Texto completoCheng, Adam Z., Sofia N. Moraes, Nadine M. Shaban, Elisa Fanunza, Craig J. Bierle, Peter J. Southern, Wade A. Bresnahan, Stephen A. Rice y Reuben S. Harris. "APOBECs and Herpesviruses". Viruses 13, n.º 3 (28 de febrero de 2021): 390. http://dx.doi.org/10.3390/v13030390.
Texto completoGuo, Honghong, Ling Zhu, Lu Huang, Zhen Sun, Hui Zhang, Baoting Nong y Yuanyan Xiong. "APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer". Cancers 14, n.º 12 (8 de junio de 2022): 2827. http://dx.doi.org/10.3390/cancers14122827.
Texto completoDelebecque, Frédéric, Rodolphe Suspène, Sara Calattini, Nicoletta Casartelli, Ali Saïb, Alain Froment, Simon Wain-Hobson, Antoine Gessain, Jean-Pierre Vartanian y Olivier Schwartz. "Restriction of Foamy Viruses by APOBEC Cytidine Deaminases". Journal of Virology 80, n.º 2 (15 de enero de 2006): 605–14. http://dx.doi.org/10.1128/jvi.80.2.605-614.2006.
Texto completoWiegand, Heather L. y Bryan R. Cullen. "Inhibition of Alpharetrovirus Replication by a Range of Human APOBEC3 Proteins". Journal of Virology 81, n.º 24 (3 de octubre de 2007): 13694–99. http://dx.doi.org/10.1128/jvi.01646-07.
Texto completoZheng, Yong-Hui, Dan Irwin, Takeshi Kurosu, Kenzo Tokunaga, Tetsutaro Sata y B. Matija Peterlin. "Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication". Journal of Virology 78, n.º 11 (1 de junio de 2004): 6073–76. http://dx.doi.org/10.1128/jvi.78.11.6073-6076.2004.
Texto completoWalker, Brian A., Christopher P. Wardell, Alexander Murison, Eileen M. Boyle, Lorenzo Melchor, Charlotte Pawlyn, Martin F. Kaiser et al. "Apobec Family Mutational Signatures Are Associated with Poor Prognosis Translocations in Multiple Myeloma". Blood 124, n.º 21 (6 de diciembre de 2014): 723. http://dx.doi.org/10.1182/blood.v124.21.723.723.
Texto completoMalim, Michael H. "APOBEC proteins and intrinsic resistance to HIV-1 infection". Philosophical Transactions of the Royal Society B: Biological Sciences 364, n.º 1517 (27 de noviembre de 2008): 675–87. http://dx.doi.org/10.1098/rstb.2008.0185.
Texto completoWurtzer, Sebastien, Armelle Goubard, Fabrizio Mammano, Sentob Saragosti, Denise Lecossier, Allan J. Hance y François Clavel. "Functional Central Polypurine Tract Provides Downstream Protection of the Human Immunodeficiency Virus Type 1 Genome from Editing by APOBEC3G and APOBEC3B". Journal of Virology 80, n.º 7 (1 de abril de 2006): 3679–83. http://dx.doi.org/10.1128/jvi.80.7.3679-3683.2006.
Texto completoVieira, Valdimara C. y Marcelo A. Soares. "The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections". BioMed Research International 2013 (2013): 1–18. http://dx.doi.org/10.1155/2013/683095.
Texto completoHolland, Stephen J., Lesley M. Berghuis, Justin J. King, Lakshminarayan M. Iyer, Katarzyna Sikora, Heather Fifield, Sarah Peter et al. "Expansions, diversification, and interindividual copy number variations of AID/APOBEC family cytidine deaminase genes in lampreys". Proceedings of the National Academy of Sciences 115, n.º 14 (19 de marzo de 2018): E3211—E3220. http://dx.doi.org/10.1073/pnas.1720871115.
Texto completoChen, Xiaojiang S. "Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions". Viruses 13, n.º 3 (17 de marzo de 2021): 497. http://dx.doi.org/10.3390/v13030497.
Texto completoGhorbani, Atefeh, Justin J. King y Mani Larijani. "The optimal pH of AID is skewed from that of its catalytic pocket by DNA-binding residues and surface charge". Biochemical Journal 479, n.º 1 (6 de enero de 2022): 39–55. http://dx.doi.org/10.1042/bcj20210529.
Texto completoBlanc, Valerie, Jeffrey O. Henderson, Elizabeth P. Newberry, Susan Kennedy, Jianyang Luo y Nicholas O. Davidson. "Targeted Deletion of the Murine apobec-1 Complementation Factor (acf) Gene Results in Embryonic Lethality". Molecular and Cellular Biology 25, n.º 16 (15 de agosto de 2005): 7260–69. http://dx.doi.org/10.1128/mcb.25.16.7260-7269.2005.
Texto completoStewart, Jessica A., Grant Schauer y Ashok S. Bhagwat. "Visualization of uracils created by APOBEC3A using UdgX shows colocalization with RPA at stalled replication forks". Nucleic Acids Research 48, n.º 20 (19 de octubre de 2020): e118-e118. http://dx.doi.org/10.1093/nar/gkaa845.
Texto completoMayekar, Manasi, Deborah Caswell, Natalie Vokes, Emily K. Law, Wei Wu, William Hill, Eva Gronroos et al. "Abstract 2197: Targeted cancer therapy induces APOBEC fueling the evolution of drug resistance". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2197. http://dx.doi.org/10.1158/1538-7445.am2022-2197.
Texto completoSiu, Karen, Azmiri Sultana, Farshad Azimi y Jeffrey Lee. "Structural determinants of ssDNA- and HIV-1 Vif-binding in APOBEC3F". Acta Crystallographica Section A Foundations and Advances 70, a1 (5 de agosto de 2014): C118. http://dx.doi.org/10.1107/s2053273314098817.
Texto completoTakaori-Kondo, Akifumi. "APOBEC Family Proteins: Novel Antiviral Innate Immunity". International Journal of Hematology 83, n.º 3 (1 de abril de 2006): 213–16. http://dx.doi.org/10.1532/ijh97.05187.
Texto completoRiva, Giuseppe, Camilla Albano, Francesca Gugliesi, Selina Pasquero, Sergio Fernando Castillo Pacheco, Giancarlo Pecorari, Santo Landolfo, Matteo Biolatti y Valentina Dell’Oste. "HPV Meets APOBEC: New Players in Head and Neck Cancer". International Journal of Molecular Sciences 22, n.º 3 (30 de enero de 2021): 1402. http://dx.doi.org/10.3390/ijms22031402.
Texto completoDoehle, Brian P., Alexandra Schäfer, Heather L. Wiegand, Hal P. Bogerd y Bryan R. Cullen. "Differential Sensitivity of Murine Leukemia Virus to APOBEC3-Mediated Inhibition Is Governed by Virion Exclusion". Journal of Virology 79, n.º 13 (1 de julio de 2005): 8201–7. http://dx.doi.org/10.1128/jvi.79.13.8201-8207.2005.
Texto completoLerner, Taga, F. Papavasiliou y Riccardo Pecori. "RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease". Genes 10, n.º 1 (27 de diciembre de 2018): 13. http://dx.doi.org/10.3390/genes10010013.
Texto completoAnant, Shrikant, Debnath Mukhopadhyay, Vakadappu Sankaranand, Susan Kennedy, Jeffrey O. Henderson y Nicholas O. Davidson. "ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing". American Journal of Physiology-Cell Physiology 281, n.º 6 (1 de diciembre de 2001): C1904—C1916. http://dx.doi.org/10.1152/ajpcell.2001.281.6.c1904.
Texto completoShapiro, Kate, Maxwell Shapiro y Thomas MacCarthy. "#84: Evolutionary Pressure from APOBEC Causes an Underrepresentation of TC Motifs in Human Polyomavirus". Journal of the Pediatric Infectious Diseases Society 10, Supplement_1 (1 de marzo de 2021): S14—S15. http://dx.doi.org/10.1093/jpids/piaa170.043.
Texto completoPilzecker, Bas, Olimpia Alessandra Buoninfante, Colin Pritchard, Olga S. Blomberg, Ivo J. Huijbers, Paul C. M. van den Berk y Heinz Jacobs. "PrimPol prevents APOBEC/AID family mediated DNA mutagenesis". Nucleic Acids Research 44, n.º 10 (28 de febrero de 2016): 4734–44. http://dx.doi.org/10.1093/nar/gkw123.
Texto completoConticello, Silvestro G. "The AID/APOBEC family of nucleic acid mutators". Genome Biology 9, n.º 6 (2008): 229. http://dx.doi.org/10.1186/gb-2008-9-6-229.
Texto completoKazuma, Yasuhiro, Kotaro Shirakawa, Anamaria Daniela Sarca, Yoshihito Horisawa, Hirofumi Fukuda, Hiroyuki Matsui, Hiroyuki Yamazaki et al. "Interactome Analysis of APOBEC3B in Multiple Myeloma". Blood 134, Supplement_1 (13 de noviembre de 2019): 1259. http://dx.doi.org/10.1182/blood-2019-126856.
Texto completoChu, Charles C., Piers E. M. Patten, Thomas MacCarthy, Chaohui Yuan, Xiao-Jie Yan, Jacqueline C. Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti R. Rai y Nicholas Chiorazzi. "IGHV-D-J Ultra-Deep Sequencing Reveals APOBEC and AID Targeted Mutations during Clonal Evolution of CLL in a Xenograft Mouse Model". Blood 124, n.º 21 (6 de diciembre de 2014): 300. http://dx.doi.org/10.1182/blood.v124.21.300.300.
Texto completoBrowne, Edward P. y Dan R. Littman. "Species-Specific Restriction of Apobec3-Mediated Hypermutation". Journal of Virology 82, n.º 3 (21 de noviembre de 2007): 1305–13. http://dx.doi.org/10.1128/jvi.01371-07.
Texto completoSmith, Harold C., Ryan P. Bennett, Ayse Kizilyer, William M. McDougall y Kimberly M. Prohaska. "Functions and regulation of the APOBEC family of proteins". Seminars in Cell & Developmental Biology 23, n.º 3 (mayo de 2012): 258–68. http://dx.doi.org/10.1016/j.semcdb.2011.10.004.
Texto completoVerhalen, Brandy, Gabriel J. Starrett, Reuben S. Harris y Mengxi Jiang. "Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses". Journal of Virology 90, n.º 14 (4 de mayo de 2016): 6379–86. http://dx.doi.org/10.1128/jvi.00771-16.
Texto completoChelico, Linda. "Special Issue “APOBECs and Virus Restriction”". Viruses 13, n.º 8 (15 de agosto de 2021): 1613. http://dx.doi.org/10.3390/v13081613.
Texto completoStefanovska, Bojana, Kevin Lin, Benjamin Troness, Chad Myers y Reuben Harris. "Abstract P2-17-01: Targeted CRISPR screen to identify synthetic lethal combinations between APOBEC3B and DNA repair". Cancer Research 83, n.º 5_Supplement (1 de marzo de 2023): P2–17–01—P2–17–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p2-17-01.
Texto completoVázquez, Nancy, Hana Schmeisser, Michael A. Dolan, Joseph Bekisz, Kathryn C. Zoon y Sharon M. Wahl. "Structural variants of IFNα preferentially promote antiviral functions". Blood 118, n.º 9 (1 de septiembre de 2011): 2567–77. http://dx.doi.org/10.1182/blood-2010-12-325027.
Texto completoKanabe, Belan O., Mehmet Ozaslan, Sherwan Ahmed Aziz, Mustafa S. Al-Attar, İbrahim Halil Kılıç y Rozhgar A. Khailany. "Expression patterns of LncRNA-GAS5 and its target APOBEC3C gene through miR-103 in breast cancer patients". Cellular and Molecular Biology 67, n.º 3 (25 de noviembre de 2021): 5–10. http://dx.doi.org/10.14715/cmb/2021.67.3.2.
Texto completoZotova, Irina, Elena Stepchenkova y Youri Pavlov. "Contribution of cytosine desaminases of AID/APOBEC family to carcinogenesis". Biological Communications 64, n.º 2 (2019): 110–23. http://dx.doi.org/10.21638/spbu03.2019.203.
Texto completoSalter, Jason D., Ryan P. Bennett y Harold C. Smith. "The APOBEC Protein Family: United by Structure, Divergent in Function". Trends in Biochemical Sciences 41, n.º 7 (julio de 2016): 578–94. http://dx.doi.org/10.1016/j.tibs.2016.05.001.
Texto completoTurelli, Priscilla, Alexandra Liagre-Quazzola, Bastien Mangeat, Sonia Verp, Stephanie Jost y Didier Trono. "APOBEC3-Independent Interferon-Induced Viral Clearance in Hepatitis B Virus Transgenic Mice". Journal of Virology 82, n.º 13 (23 de abril de 2008): 6585–90. http://dx.doi.org/10.1128/jvi.00216-08.
Texto completoRogozin, Igor B., Malay K. Basu, I. King Jordan, Youri I. Pavlov y Eugene V. Koonin. "APOBEC4, a New Member of the AID/APOBEC Family of Polynucleotide (Deoxy)Cytidine Deaminases Predicted by Computational Analysis". Cell Cycle 4, n.º 9 (6 de julio de 2005): 1281–85. http://dx.doi.org/10.4161/cc.4.9.1994.
Texto completoAnderson, Brett D. y Reuben S. Harris. "Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis". Science Advances 1, n.º 8 (septiembre de 2015): e1500296. http://dx.doi.org/10.1126/sciadv.1500296.
Texto completo